Treatment of diabetes is now limited to insulin injections, but might be replaced by restoration of beta cells by stem cell therapy in the future
Improved stem cell therapy to prolong the life and functionality of beta cells - health short science news

As restoration of the amount of beta cells, the ones producing insulin, in the pancreas is often met by attacks from the immune system, researchers have sought to find a stem cell therapy that would prevent activation of the immune system and turn the stem cells into viable and functional insulin-producing cells.

Now, scientists have made use of the immune-repellent chemokine (a messenger of the immune system that reduces immune system activation) CXCL12 in the capsule gel in which stem cells are delivered into the body. In diabetic mice, the addition of CXCL12 to the capsule restored glucose metabolism and protected the stem cells and newly-formed beta cells against the body’s immune response.

This study brings the restoration of beta cells seen in diabetics an important step closer.

Read the full story: Massachusetts General Hospital
Scientific publication: American Journal of Transplantation